Founded Date:
2026
Industry:
iPSC platforms, exosome quality systems, AI-driven biomarker innovation; protocol design for global deployment; R&D hub status.
Headquarters:
https://aivitahealth.group/
Technology:
iPSC/stem cells, exosomes, AI health analytics, precision longevity
Funding Status:
Aivita Bio (Aivita Health Group).png